arrow
J

James D. Berry

mass-general brigham
H指数:55
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Functional Activity of TDP-43: A Direct Biomarker for ALS

TDP-43的功能活性:肌萎缩侧索硬化症的直接生物标志物

2026-08-260
OA
Design considerations for C9orf72 disease prevention trials

C9orf72疾病预防试验的设计考虑

BRAIN
IF11.7
2025-10-010
OAAI
Real-World Clinical Experience With Sodium Phenylbutyrate and Taurursodiol at a Single Amyotrophic Lateral Sclerosis Center in the United States

美国一家肌萎缩侧索硬化症中心中钠苯丁酸盐和Taurursodiol的实际临床应用经验

2025-09-180
OAAI
Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large-Scale, Multi-Cohort Proteomic Study

肌萎缩侧索硬化症的骨骼肌生物标志物:一项大规模、多队列的蛋白质组学研究

2025-09-010
PRE
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis

多中心扩展性访问方案:通过向肌萎缩侧索硬化症患者提供海藻糖进行研究

2025-08-260
OAAI
Listener effort measures clinically meaningful change of dysarthria in amyotrophic lateral sclerosis

听者努力测量肌萎缩侧索硬化症中构音障碍的临床意义变化

2025-06-120
OAAI
Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis

脑脊液蛋白质组网络分析揭示了散发性与家族性肌萎缩侧索硬化症之间的共享及独特差异

2025-05-150
OA
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis, A Randomized Clinical Trial

Zilucoplan治疗肌萎缩侧索硬化症的疗效与安全性:一项随机临床试验

2025-02-173
OA
Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocols (vol 14,21837,2024)

TDP-43在血小板中的位置和功能,神经退行性疾病的改变以及当前血浆生物库方案的考虑因素 (第14卷,21837,2024)

2024-11-070
OAAI